MAPK3 and Alzheimer disease: Our data further showed that the pro-paracrine, anti-apoptotic and anti-oxidative function of CB2 agonist on AD-MSCs was associated with CB2 activation and subsequent Stat3 activation mediated by the Akt and Erk1/2.